New Treatments for Drug-Resistant Epilepsy that Target Presynaptic Transmitter Release
Abstract
We developed electrophysiological, two-photon laser scanning microscopic imaging and pharmacological tools to investigate the effects of levetiracetam, topiramate and carbamazepine on excitatory (glutamatergic) synaptic transmission and vesicular transmitter release at multiple synapses in in-vitro brain slices from control and pilocarpine-treated epileptic rates and mice. We discovered that levetiracetam was more effective in reducing the frequency of excitatory synaptic transmission onto dentate granule cells in slices from chronically epileptic rates, while no significant effect was detected in the amplitude of mEPSCs, indicating a presynaptic site of action without postsynaptic effects of AMPA glutamate receptors.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 01, 2013
- Accession Number
- ADA580461
Entities
People
- Patric K. Stanton
Organizations
- New York Medical College